Pinnacle Associates LTD Corbus Pharmaceuticals Holdings, Inc. Transaction History

Pinnacle Associates LTD

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	SELL	$0.11 - $5.46 $78,404 - $3.89 Million	-712,770 Reduced 97.46%	18,580 $2,000
Q4 2022 Jan 25, 2023	SELL	$0.11 - $5.46 $10,547 - $523,559	-95,890 Reduced 11.59%	731,350 $0
Q3 2022 Oct 31, 2022	SELL	$0.17 - $5.31 $14,070 - $439,487	-82,766 Reduced 9.1%	827,240 $136,000
Q2 2022 Aug 02, 2022	SELL	$0.21 - $0.53 $1,025 - $2,586	-4,881 Reduced 0.53%	910,006 $230,000
Q1 2022 May 05, 2022	SELL	$0.32 - $0.67 $10,302 - $21,571	-32,196 Reduced 3.4%	914,887 $486,000
Q4 2021 Feb 02, 2022	SELL	$0.6 - $1.11 $11,358 - $21,013	-18,931 Reduced 1.96%	947,083 $583,000
Q3 2021 Oct 19, 2021	SELL	$1.01 - $1.82 $32,537 - $58,631	-32,215 Reduced 3.23%	966,014 $985,000
Q2 2021 Aug 02, 2021	BUY	$1.39 - $2.21 $20,780 - $33,039	14,950 Added 1.52%	998,229 $1.83 Million
Q1 2021 May 12, 2021	BUY	$1.27 - $3.42 $52,324 - $140,904	41,200 Added 4.37%	983,279 $1.94 Million
Q4 2020 Jan 26, 2021	SELL	$0.94 - $1.89 $208,069 - $418,353	-221,351 Reduced 19.03%	942,079 $1.18 Million
Q3 2020 Oct 23, 2020	SELL	$1.5 - $9.38 $61,465 - $384,364	-40,977 Reduced 3.4%	1,163,430 $2.09 Million
Q2 2020 Aug 14, 2020	SELL	$4.79 - $8.39 $5.86 Million - $10.3 Million	-1,223,777 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$3.44 - $7.21 $4.21 Million - $8.82 Million	1,223,777 New	1,223,777 $6.41 Million

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.05B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

Stay updated on Pinnacle Associates LTD with notifications on news.